The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infants.
about
Focal necrosis and disturbed myelination in the white matter of newborn infants: a tale of too much or too little oxygenEffect of different assumptions for brain water content on absolute measures of cerebral oxygenation determined by frequency-domain near-infrared spectroscopy in preterm infants: an observational study.A comparison between two NIRS oximeters (INVOS, OxyPrem) using measurement on the arm of adults and head of infants after caesarean sectionNear-infrared spectroscopy as a predictor of clinical deterioration: a case report of two infants with duct-dependent congenital heart disease.Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trialCerebral oximetry in preterm infants: an agenda for research with a clear clinical goal.The SafeBoosC phase II clinical trial: an analysis of the interventions related with the oximeter readingsFunctional near infrared spectroscopy as a probe of brain function in people with prolonged disorders of consciousnessPrediction of Outcome in Neonates with Hypoxic-Ischemic Encephalopathy II: Role of Amplitude-Integrated Electroencephalography and Cerebral Oxygen Saturation Measured by Near-Infrared Spectroscopy.Brain injury in the international multicenter randomized SafeBoosC phase II feasibility trial: cranial ultrasound and magnetic resonance imaging assessments.Neonatal brain oxygenation during thoracoscopic correction of esophageal atresia.The SafeBoosC II randomized trial: treatment guided by near-infrared spectroscopy reduces cerebral hypoxia without changing early biomarkers of brain injury.Decompressing posthaemorrhagic ventricular dilatation significantly improves regional cerebral oxygen saturation in preterm infants.Golden hour of neonatal life: Need of the hour.Comparison of tissue oximeters on a liquid phantom with adjustable optical properties.Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trial.Cerebral near-infrared spectroscopy monitoring for prevention of brain injury in very preterm infants.Cerebral haemorrhage in preterm neonates: does cerebral regional oxygen saturation during the immediate transition matter?Avoiding Arterial Hypotension in Preterm Neonates (AHIP)-A Single Center Randomised Controlled Study Investigating Simultaneous Near Infrared Spectroscopy Measurements of Cerebral and Peripheral Regional Tissue Oxygenation and Dedicated InterventionThe impact of integrated evaluation of hemodynamics using targeted neonatal echocardiography with indices of tissue oxygenation: a new approach.Sharing Progress in Neonatal (SPIN) Brain, Gut, Heart, and Lung.Association between Brain and Kidney Near-Infrared Spectroscopy and Early Postresuscitation Mortality in Asphyxiated Newborn Piglets.Interpretation of Cerebral Oxygenation Changes in the Preterm Infant
P2860
Q26852926-3B9AB542-A3D3-4E9A-8901-2576B8F47BBEQ34088977-8FF3BA62-A18D-4F8B-A2C9-7560D83306FEQ34387673-A042A0F9-CF64-4BC7-96E1-42ABF9F55BA6Q36311172-DA900ECB-F4B8-49FC-9DDB-4FED8EC69769Q36318394-6E559032-FC9C-473A-9966-7B08598D49F9Q36827998-7312B5A2-DEC3-4F93-A9D5-B285FA970F73Q37085568-A8CC65BA-1CDE-4945-BFDC-608A4538C187Q37171681-482151AA-06F8-4B94-95F1-19D536C681DDQ38680712-FAB9BD9B-F9FF-4877-B4F6-9DD272E6207EQ38942492-0CCF0E32-859D-46E5-8ACE-BAF9B1A0E825Q38951019-E259F68A-D1C4-4AEC-9F62-67A227C2398AQ40200067-C3A4DD50-2383-45B3-8934-AD2FD60E08F8Q41530358-F8B3BF69-710E-45BB-8D0E-8D4FCAB5CAAFQ41716215-825AFE93-BE4F-4AF3-9B5E-93CA828C7468Q41749559-1E0D9415-8473-41B4-8876-7AB437551DAFQ42152343-7FEE34B3-159D-4360-8935-145FD2108AB1Q48128164-D1A0B664-0C52-4A88-9784-6035CC12F0F5Q48133053-B71A7BC1-7E17-420F-B743-608A80579434Q49478320-559E72AE-BF0F-48F3-B2AA-D1F0E7399808Q50945525-45A24FDB-8EB5-4809-A79E-114C505D790BQ52093921-51A999E8-8534-4BCD-BCAE-8675B60A215CQ52099879-F006B0BE-7698-4230-B38D-FC9B7F25FC7AQ57260305-30F17142-3064-4FD3-8968-937D430B65B7
P2860
The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infants.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The SafeBoosC phase II randomi ...... in extremely preterm infants.
@en
type
label
The SafeBoosC phase II randomi ...... in extremely preterm infants.
@en
prefLabel
The SafeBoosC phase II randomi ...... in extremely preterm infants.
@en
P2093
P2860
P50
P356
P1433
P1476
The SafeBoosC phase II randomi ...... t in extremely preterm infants
@en
P2093
Adelina Pellicer
Claudia Roll
Frank van Bel
Gunnar Naulaers
Manon Benders
Maria Skoog
Martin Wolf
Olivier Claris
Petra Lemmers
Simon Hyttel-Sorensen
P2860
P304
P356
10.1159/000351346
P407
P50
P577
2013-08-01T00:00:00Z